Circulating CLA<sup>+</sup> T cells in atopic dermatitis and their possible role as peripheral biomarkers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27861978.
- Also identified by DOI 10.1111/all.13080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cutaneous lymphocyte-associated antigen (CLA<sup>+</sup> ) T cells are specialized for skin homing and represent the main T-cell population in atopic dermatitis (AD) lesions. CLA<sup>+</sup> is expressed on the surface of circulating CD45RO<sup>+</sup> memory T cells and most skin-infiltrating T cells. Mechanistic studies and thus treatment advancements are limited by the need of large number of skin biopsies. Circulating CLA<sup>+</sup> T cells may be a reliable surrogate marker of the inflammatory events occurring in the skin, and thus, the evaluation of CLA<sup>+</sup> T cells in the blood may eliminate the need for skin biopsies. Preliminary work in AD has established that disease-associated T-cell abnormalities can be approached by either a study of skin lesions or activated CLA<sup>+</sup> T-cell subsets in peripheral blood. Future studies in adults and children, across different skin disorders, correlating blood and skin phenotypes and determining skin-homing T-cell functional properties are needed to establish whether CLA<sup>+</sup> memory subsets can be used as biomarkers and a substitute for skin biopsies. This review summarizes the latest advancements reached on circulating CLA<sup>+</sup> in AD and the great potential they harbor in understanding AD mechanisms.
Medical subject headings
- Antigens, Differentiation, T-Lymphocyte
- Dermatitis, Atopic
- Membrane Glycoproteins
- T-Lymphocyte Subsets